Mangangot, Mark Caleb R.
HRN: 24-14-40 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/07/2025
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
01/07/2025
01/14/2025
IV
210 Mg
Q6h
Pcap C
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes